Bionor Pharma ASA - Mandatory notification of trade - Lars H Høie
STOCK EXCHANGE ANNOUNCEMENT
Reference is made to the announcement by Bionor Pharma ASA on 14 December 2016 regarding completion of EGM.
Upon issuance of the Consideration Shares, the shares in the Private Placement and the shares in the Subsequent Offering, Lars H. Høie will hold 128,973,522 shares and votes in the Company, corresponding to 1.33% of the total share capital and votes of the Company.
This information is subject to the disclosure requirements set out in section 4-3 of the Norwegian Securities Trading Act.Bionor_SEA20161215_MandatoryNotificationOfTrade_Hoie
Last updated on: 16/12/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.